Taro Receives Final FDA Approval for Carbamazepine Extended-Release Tablets
03 avr. 2009 08h34 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., April 3, 2009 (GLOBE NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company") (Pink Sheets:TAROF) today reported that it received final approval from the U.S. Food...
Taro Receives FDA Approval for Levetiracetam Oral Solution
11 févr. 2009 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Feb. 11, 2009 (GLOBE NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) reported today that it has received approval from the U.S. Food and...
Taro Receives FDA Warning Letter Following Inspection of Its Canadian Manufacturing Facility
06 févr. 2009 12h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Feb. 6, 2009 (GLOBE NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company,") (Pink Sheets:TAROF) announced that yesterday, February 5, 2009, it received a warning...
Taro Receives Final FDA Approval for Lamotrigine Chewable Tablets ANDA
05 févr. 2009 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Feb. 5, 2009 (GLOBE NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company,") (Pink Sheets:TAROF) reported today that it has received final approval from the U.S. Food...
Taro Provides Preliminary 2008 Full Year Results
02 févr. 2009 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
Net Income in 2008 Increases 143% to $51 Million From
$21 Million in 2007
$74 Million Net Cash Generated From Operations in 2008
HAWTHORNE, N.Y., Feb. 2,...
Taro Receives Final FDA Approval for Lamotrigine Tablets ANDA
28 janv. 2009 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Jan. 28, 2009 (GLOBE NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company,") (Pink Sheets:TAROF) reported today that it has received final approval from the U.S....
Sun Refuses to Accept Taro's Offer to Mediate
06 janv. 2009 11h17 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Jan. 6, 2009 (GLOBE NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company,") (Pink Sheets:TAROF) said today that Sun Pharmaceutical Industries Ltd. ("Sun") has...
Taro Files Form 6-K Supplementing Its Preliminary Third Quarter and Year-to-Date 2008 Financial Results
18 déc. 2008 17h30 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Dec. 18, 2008 (GLOBE NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) today filed a Form 6-K with the Securities and Exchange Commission...
Taro Provides Preliminary Third Quarter and Year-to-Date 2008 Financial Results
11 nov. 2008 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
Net Income Year-to-Date 2008 Exceeds Full-Year 2007 Net Income and
is More than Double the Comparable Year Ago Period
$40.7 Million Net Cash Generated from Operations Year-to-Date...
Taro Sends Letter to Update Shareholders On Status of Litigation With Sun
10 sept. 2008 07h00 HE
|
Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., Sept. 10, 2008 (GLOBE NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. ("Taro," the "Company,") (Pink Sheets:TAROF) today announced that it is sending a letter to its shareholders...